News Directory

Keep up to date with MTPConnect news and events, updated regularly. If you have news or events the sector would be interested to hear about, please let us know at media@mtpconnect.org.au.

News


24 January 2024

Join the Australian delegation to BIO2024 in San Diego, backed by MTPConnect

MTPConnect is excited to lead this year’s BIO2024 mission to San Diego from 3 – 6 June to showcase Australia’s outstanding life science innovations, innovators and unique biotechnology, pharmaceutical and manufacturing capabilities. Find out how to join the Australian delegation...

24 January 2024

How to nominate for the Prime Minister’s Prizes for Science in 5 easy steps

Show someone how much you value their contribution by nominating them for the 2024 Prime Minister’s Prizes for Science. Nominations open until 8 February 2024.

23 January 2024

Apply for UQ's Ventures Empower Program

Calling all entrepreneurs who are women and in the early stages of founding their startup!

17 January 2024

SA Insights Event: Funding Programs that drive Australia's healthtech innovations

Join host, Director for the Adelaide Intermediary Program, Jo Close, who will chat to six distinguished leaders, each representing national funding programs that drive Australia's healthtech innovations for the first SA Insights Event of 2024!

12 January 2024

In Case You Missed It: Here’s What The MTPConnect Team Has Been Up To in December

Check out what MTPConnect got up to in December!

11 January 2024

The Bridge Program – Applications Now Open!

The Bridge Program trains researchers and clinicians to navigate the pharmaceutical and biotech commercialisation pathway, as well as expanding their pharmaceutical commercialisation knowledge and networks. Find out more and apply now!

22 December 2023

BridgeTech Program Applications Open

Applications for the award-winning BridgeTech Program are now open for 2024!

21 December 2023

2023 Annual Report Out Now

Take a look at our 2023 Annual Report, out now!

20 December 2023

ASHRA Partnering Summit - Partnering for Translation and Building an Innovation Culture

MTPConnect’s TTRA program has co-hosted the Australian Stroke and Heart Research Accelerator (ASHRA) 2023 Annual Partnering Summit at the Victorian Heart Hospital in Clayton, Melbourne recently. With over 110 guests from industry, academia, research institutes, the health sector and government, it was an opportunity to learn, contribute and connect.

18 December 2023

WA Hub Kicks off New Year with Spotlight on Commercialising Medtech from a US and Australian Perspective

The WA Life Sciences Innovation Hub kicks off its first WA MTP Sector Spotlight Series event for 2024 with a fireside chat on medtech commercialisation from US and Australian perspectives with OncoRes Medicals' Jill Anderson and Dr Kath Giles.

15 December 2023

Moving from Academia to Industry - Podcast Highlights GSK’s Graduate Researcher Program

With the REDI-supported Graduate Researcher Program coming to a close, the MTPConnect podcast team headed to GSK Australian headquarters in Abbotsford, to find out more about the impact of the GSK Graduate Researcher Program (GRP) from graduates and staff.

14 December 2023

Austrian Medtech Opens Down Under Inspired by REDI Fellowship and Quality of Australian Research

Based in Vienna, Austria, TissueGnostics is an innovative medtech company recognised as a leading global provider of state-of-the-art tissue cytometers. After being awarded one of our REDI Fellowships, TissueGnostics was so impressed with the calibre of Australian academic research it opened a subsidiary down under.

14 December 2023

In Case You Missed It: Here’s What The MTPConnect Team Has Been Up To in November

Check out what MTPConnect got up to in November!

14 December 2023

MTPConnect Strengthens Life Science Links Through MoU with Korea Health Industry Development Institute

With the execution of a new Memorandum of Understanding (MoU), MTPConnect and the Korea Health Industry Development Institute (KHIDI) have committed to working closely together to support the growth of health and medical technology, biotechnology and pharmaceutical companies in each country.